Substance P/neurokinin1 receptor is associated with the expression of cardiac stem/pluripotency-associated genes in diabetic right and left atria

Substance P (SP) is a cardioprotective neuropeptide that interacts with the G protein-coupled neurokinin-1 receptor (NK1R). Although the expression of SP/NK1R in the right atrium (RA) of diabetic patients is known to be significantly impaired, the molecular mechanism remains unclear. LETO and OLETF rats were randomly divided into 3 groups: saline, SP injection (5 nmole/kg), and SP+RP injection (1 mg/kg RP67580, a selective non-peptide tachykinin NK1R antagonist). After 3 weeks, the left atrium (LA), RA, and left ventricle (LV) of the rats were collected. Cardiac stem/pluripotency-associated genes in the diabetic atria of each group were comprehensively examined using qRT-PCR analysis. qRT-PCR analysis demonstrated that only the RA of SP-treated OLETF rats exhibited significantly higher levels of alpha-SMA, GATA4, TBX5, and Klf4 in the mRNA, compared to the control. RP prevented the expression of NK1R and four SP-associated genes in the RA of SP-treated OLETF rats. In conclusion, our findings provide novel mechanistic insights into the role of NK1R in diabetic atria.

[1]  Tianyi Liu,et al.  Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration , 2021, Signal Transduction and Targeted Therapy.

[2]  A. Kroon,et al.  Associations of (pre)diabetes with right ventricular and atrial structure and function: the Maastricht Study , 2020, Cardiovascular Diabetology.

[3]  C. Cuspidi,et al.  Left atrial function in diabetes: does it help? , 2020, Acta Diabetologica.

[4]  R. Ritchie,et al.  Basic Mechanisms of Diabetic Heart Disease. , 2020, Circulation research.

[5]  Kiyoshi Yoshida,et al.  Subtypes of Atrial Functional Mitral Regurgitation: Imaging Insights Into Their Mechanisms and Therapeutic Implications. , 2020, JACC. Cardiovascular imaging.

[6]  X. Cheng,et al.  Substance P Administered after Myocardial Infarction Upregulates Microphthalmia-Associated Transcription Factor, GATA4, and the Expansion of c-Kit+ Cells , 2020, Stem cells international.

[7]  M. Nemer,et al.  From embryogenesis to adulthood: Critical role for GATA factors in heart development and function , 2020, IUBMB life.

[8]  L. B. Maifrino,et al.  Ultrastructural effects of diabetes in the right atrium cardiomyocytes of elderly Wistar rats. , 2019, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[9]  S. Nattel,et al.  Right Atrial Mechanisms of Atrial Fibrillation in a Rat Model of Right Heart Disease. , 2019, Journal of the American College of Cardiology.

[10]  X. Cheng,et al.  Substance P enhances the local activation of NK1R-expressing c-kit+ cardiac progenitor cells in right atrium of ischemia/reperfusion-injured heart , 2019, BMC Molecular and Cell Biology.

[11]  M. Słoniecka,et al.  Substance P induces fibrotic changes through activation of the RhoA/ROCK pathway in an in vitro human corneal fibrosis model , 2019, Journal of Molecular Medicine.

[12]  N. Frangogiannis,et al.  Fibroblasts in the Infarcted, Remodeling, and Failing Heart , 2019, JACC. Basic to translational science.

[13]  K. Sung,et al.  Longitudinal changes in left ventricular structure and function in patients with type 2 diabetes: Normal weight versus overweight/obesity , 2019, Diabetes & vascular disease research.

[14]  N. Wong,et al.  Epidemiology of Diabetes Mellitus and Cardiovascular Disease , 2019, Current Cardiology Reports.

[15]  Stefan Konigorski,et al.  Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine. , 2019, Metabolism: clinical and experimental.

[16]  E. Olson,et al.  Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease , 2018, Development.

[17]  W. Kummer,et al.  Substance P Receptor in the Rat Heart and Regulation of Its Expression in Long-Term Diabetes , 2018, Front. Physiol..

[18]  Mónica P. A. Ferreira,et al.  Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4–NKX2-5 Interaction , 2018, Scientific Reports.

[19]  Björn Eliasson,et al.  Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes , 2017, The New England journal of medicine.

[20]  Menglan Xiang,et al.  Gata4 potentiates second heart field proliferation and Hedgehog signaling for cardiac septation , 2017, Proceedings of the National Academy of Sciences.

[21]  Sachin B. Malik,et al.  The right atrium: gateway to the heart--anatomic and pathologic imaging findings. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[22]  F. Logerfo,et al.  Expression of Neuropeptide Y, Substance P, and Their Receptors in the Right Atrium of Diabetic Patients , 2011, Clinical and translational science.

[23]  P. Schauerte,et al.  Association of echocardiographic atrial size and atrial fibrosis in a sequential model of congestive heart failure and atrial fibrillation. , 2008, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[24]  M. Barbosa,et al.  Left ventricle diastolic dysfunction in diabetes: an update. , 2007, Arquivos brasileiros de endocrinologia e metabologia.

[25]  Y. Saijoh,et al.  Tbx5 specifies the left/right ventricles and ventricular septum position during cardiogenesis , 2003, Development.

[26]  B. Black,et al.  Transcription factor pathways and congenital heart disease. , 2012, Current topics in developmental biology.